rs992828062

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_001127222.2(CACNA1A):​c.3464A>T​(p.Asn1155Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000216 in 1,390,118 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N1155S) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 29)
Exomes 𝑓: 0.0000022 ( 0 hom. )

Consequence

CACNA1A
NM_001127222.2 missense

Scores

1
3
14

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.843

Publications

0 publications found
Variant links:
Genes affected
CACNA1A (HGNC:1388): (calcium voltage-gated channel subunit alpha1 A) Voltage-dependent calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, and gene expression. Calcium channels are multisubunit complexes composed of alpha-1, beta, alpha-2/delta, and gamma subunits. The channel activity is directed by the pore-forming alpha-1 subunit, whereas, the others act as auxiliary subunits regulating this activity. The distinctive properties of the calcium channel types are related primarily to the expression of a variety of alpha-1 isoforms, alpha-1A, B, C, D, E, and S. This gene encodes the alpha-1A subunit, which is predominantly expressed in neuronal tissue. Mutations in this gene are associated with 2 neurologic disorders, familial hemiplegic migraine and episodic ataxia 2. This gene also exhibits polymorphic variation due to (CAG)n-repeats. Multiple transcript variants encoding different isoforms have been found for this gene. In one set of transcript variants, the (CAG)n-repeats occur in the 3' UTR, and are not associated with any disease. But in another set of variants, an insertion extends the coding region to include the (CAG)n-repeats which encode a polyglutamine tract. Expansion of the (CAG)n-repeats from the normal 4-18 to 21-33 in the coding region is associated with spinocerebellar ataxia 6. [provided by RefSeq, Jul 2016]
CACNA1A Gene-Disease associations (from GenCC):
  • episodic ataxia type 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Illumina
  • developmental and epileptic encephalopathy, 42
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • migraine, familial hemiplegic, 1
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • spinocerebellar ataxia type 6
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
  • benign paroxysmal torticollis of infancy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial or sporadic hemiplegic migraine
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Lennox-Gastaut syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.21824703).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1ANM_001127222.2 linkc.3464A>T p.Asn1155Ile missense_variant Exon 20 of 47 ENST00000360228.11 NP_001120694.1
CACNA1ANM_001127221.2 linkc.3467A>T p.Asn1156Ile missense_variant Exon 20 of 47 ENST00000638009.2 NP_001120693.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1AENST00000360228.11 linkc.3464A>T p.Asn1155Ile missense_variant Exon 20 of 47 1 NM_001127222.2 ENSP00000353362.5
CACNA1AENST00000638009.2 linkc.3467A>T p.Asn1156Ile missense_variant Exon 20 of 47 1 NM_001127221.2 ENSP00000489913.1
CACNA1AENST00000638029.1 linkc.3476A>T p.Asn1159Ile missense_variant Exon 20 of 48 5 ENSP00000489829.1
CACNA1AENST00000573710.7 linkc.3470A>T p.Asn1157Ile missense_variant Exon 20 of 47 5 ENSP00000460092.3
CACNA1AENST00000635727.1 linkc.3467A>T p.Asn1156Ile missense_variant Exon 20 of 47 5 ENSP00000490001.1
CACNA1AENST00000637769.1 linkc.3467A>T p.Asn1156Ile missense_variant Exon 20 of 47 1 ENSP00000489778.1
CACNA1AENST00000636012.1 linkc.3467A>T p.Asn1156Ile missense_variant Exon 20 of 46 5 ENSP00000490223.1
CACNA1AENST00000637736.1 linkc.3326A>T p.Asn1109Ile missense_variant Exon 19 of 46 5 ENSP00000489861.1
CACNA1AENST00000636389.1 linkc.3467A>T p.Asn1156Ile missense_variant Exon 20 of 47 5 ENSP00000489992.1
CACNA1AENST00000637432.1 linkc.3476A>T p.Asn1159Ile missense_variant Exon 20 of 48 5 ENSP00000490617.1
CACNA1AENST00000636549.1 linkc.3467A>T p.Asn1156Ile missense_variant Exon 20 of 48 5 ENSP00000490578.1
CACNA1AENST00000637927.1 linkc.3470A>T p.Asn1157Ile missense_variant Exon 20 of 47 5 ENSP00000489715.1
CACNA1AENST00000635895.1 linkc.3467A>T p.Asn1156Ile missense_variant Exon 20 of 47 5 ENSP00000490323.1
CACNA1AENST00000637276.1 linkc.3467A>T p.Asn1156Ile missense_variant Exon 20 of 46 5 ENSP00000489777.1
CACNA1AENST00000636768.2 linkn.3467A>T non_coding_transcript_exon_variant Exon 20 of 45 5 ENSP00000490190.2
CACNA1AENST00000713789.1 linkn.3464A>T non_coding_transcript_exon_variant Exon 20 of 47 ENSP00000519091.1

Frequencies

GnomAD3 genomes
Cov.:
29
GnomAD2 exomes
AF:
0.00000533
AC:
1
AN:
187546
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000640
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000216
AC:
3
AN:
1390118
Hom.:
0
Cov.:
35
AF XY:
0.00000146
AC XY:
1
AN XY:
685772
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30832
American (AMR)
AF:
0.00
AC:
0
AN:
33490
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
21142
East Asian (EAS)
AF:
0.0000513
AC:
2
AN:
38998
South Asian (SAS)
AF:
0.0000136
AC:
1
AN:
73608
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
50148
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5384
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1079342
Other (OTH)
AF:
0.00
AC:
0
AN:
57174
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.592
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
29
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Episodic ataxia type 2;C4310716:Developmental and epileptic encephalopathy, 42 Uncertain:1
Mar 05, 2020
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces asparagine with isoleucine at codon 1156 of the CACNA1A protein (p.Asn1156Ile). The asparagine residue is moderately conserved and there is a large physicochemical difference between asparagine and isoleucine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with CACNA1A-related disease. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.23
T
BayesDel_noAF
Benign
-0.39
CADD
Benign
20
DANN
Benign
0.97
DEOGEN2
Benign
0.0
.;.;T;.;.;.;.;.;.;T;.;.;.;T;.
Eigen
Benign
-0.28
Eigen_PC
Benign
-0.17
FATHMM_MKL
Uncertain
0.91
D
LIST_S2
Uncertain
0.89
D;D;D;D;D;D;D;D;.;D;D;D;D;D;D
M_CAP
Benign
0.057
D
MetaRNN
Benign
0.22
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.0
.;.;.;.;L;.;.;.;.;.;.;.;L;.;.
PhyloP100
0.84
PrimateAI
Uncertain
0.50
T
PROVEAN
Benign
0.0
.;D;.;.;.;.;.;.;.;.;.;.;.;.;.
REVEL
Benign
0.0
Sift
Pathogenic
0.0
.;D;.;.;.;.;.;.;.;.;.;.;.;.;.
Sift4G
Benign
0.14
T;T;.;.;.;.;.;.;.;.;.;.;.;.;.
Vest4
0.57
ClinPred
0.52
D
GERP RS
2.1
Varity_R
0.26
gMVP
0.56
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs992828062; hg19: chr19-13397406; API